Annual ROE
256.97%
+793.53%+147.89%
December 31, 2023
Summary
- As of March 13, 2025, NRXPW annual return on equity is 256.97%, with the most recent change of +793.53% (+147.89%) on December 31, 2023.
- During the last 3 years, NRXPW annual ROE has risen by +138.68% (+117.24%).
- NRXPW annual ROE is now at all-time high.
Performance
NRXPW ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
127.35%
-65.76%-34.05%
September 30, 2024
Summary
- As of March 13, 2025, NRXPW quarterly return on equity is 127.35%, with the most recent change of -65.76% (-34.05%) on September 30, 2024.
- Over the past year, NRXPW quarterly ROE has stayed the same.
- NRXPW quarterly ROE is now -99.97% below its all-time high of 495.70 thousand%, reached on December 31, 2021.
Performance
NRXPW Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
NRXPW ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +147.9% | 0.0% |
| 3 y3 years | +117.2% | -99.9% |
| 5 y5 years | +3045.3% | -99.9% |
NRXPW ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +147.9% | -100.0% | +30.6% |
| 5 y | 5-year | at high | +147.9% | -100.0% | +105.0% |
| alltime | all time | at high | +147.9% | -100.0% | +105.0% |
NRx Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 127.35%(-34.1%) |
| Jun 2024 | - | 193.11%(+25.6%) |
| Mar 2024 | - | 153.75%(+32.8%) |
| Dec 2023 | 256.97%(-147.9%) | 115.81%(+18.8%) |
| Sep 2023 | - | 97.51%(-99.9%) |
| Dec 2022 | -536.56%(+20.0%) | - |
| Jun 2022 | - | 94.01 K%(-49.3%) |
| Mar 2022 | - | 185.31 K%(-62.6%) |
| Dec 2021 | -447.29% | 495.70 K%(>+9900.0%) |
| Sep 2021 | - | 2206.30%(+174.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | 802.87%(-131.8%) |
| Mar 2021 | - | -2525.38%(+876.7%) |
| Dec 2020 | 118.29%(+1347.9%) | -258.57%(+67.0%) |
| Sep 2020 | - | -154.84%(-1704.6%) |
| Jun 2020 | - | 9.65%(-8.3%) |
| Mar 2020 | - | 10.52%(+28.8%) |
| Dec 2019 | 8.17% | 8.17%(-3.4%) |
| Sep 2019 | - | 8.46%(+16.2%) |
| Jun 2019 | - | 7.28%(+93.6%) |
| Mar 2019 | - | 3.76% |
FAQ
- What is NRx Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual ROE year-on-year change?
- What is NRx Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly ROE year-on-year change?
What is NRx Pharmaceuticals annual return on equity?
The current annual ROE of NRXPW is 256.97%
What is the all time high annual ROE for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual return on equity is 256.97%
What is NRx Pharmaceuticals annual ROE year-on-year change?
Over the past year, NRXPW annual return on equity has changed by +793.53% (+147.89%)
What is NRx Pharmaceuticals quarterly return on equity?
The current quarterly ROE of NRXPW is 127.35%
What is the all time high quarterly ROE for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly return on equity is 495.70 K%
What is NRx Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, NRXPW quarterly return on equity has changed by 0.00% (0.00%)